Menu
Recruiting NCT07620470

Spectral Precise Image Study for Brain Tumors

Observational Brain Tumors

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: This is an observational data collection study.
Who it may be relevant to
Registry conditions: Brain Tumors. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Clinical Study for Exploring Image Quality the Spectral Precise Image in Patients With Diagnosed Intracranial Tumors

Overview

The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors. The main question it aims to answer is: The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions

Interventions

  • Device This is an observational data collection study
    This is an observational data collection study

Primary outcome measures

  • Subjective Image quality using Likert score (1-5) [Time frame: From date of image reconstruction until the date of image reading completion, anticipated 3Months.]
  • Objective Image Quality [Time frame: From date of image reconstruction until the date of image reading completion, anticipated 3Months.]

Eligibility criteria

Inclusion criteria

  • Patients with clinical and radiology (MRI/CT) diagnosed brain tumors.
  • Patients who underwent contrast enhanced scans using the Spectral CT 7500.
  • Study participants with age ≥ 18 years old.
  • Study participants that have signed Informed Consent Form (ICF)

Exclusion criteria

  • The clinical data or radiological information is considered incomplete after evaluation by the investigator.
  • Study participant that was enrolled in this study in the past
  • Data from study participants deemed unsuitable for enrollment based on the investigator's evaluation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-only

Study locations

China · 1 center
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan

Identifiers

NCT: NCT07620470 · 301168

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗